Avricore Health (AVCRF) Cash & Equivalents (2016 - 2025)
Historic Cash & Equivalents for Avricore Health (AVCRF) over the last 17 years, with Q3 2025 value amounting to $822631.8.
- Avricore Health's Cash & Equivalents rose 30575.44% to $822631.8 in Q3 2025 from the same period last year, while for Sep 2025 it was $822631.8, marking a year-over-year increase of 30575.44%. This contributed to the annual value of $827098.5 for FY2024, which is 30349.2% up from last year.
- Avricore Health's Cash & Equivalents amounted to $822631.8 in Q3 2025, which was up 30575.44% from $817261.5 recorded in Q2 2025.
- Over the past 5 years, Avricore Health's Cash & Equivalents peaked at $2.0 million during Q1 2021, and registered a low of $202212.3 during Q2 2024.
- In the last 5 years, Avricore Health's Cash & Equivalents had a median value of $789182.6 in 2025 and averaged $863694.5.
- Per our database at Business Quant, Avricore Health's Cash & Equivalents surged by 607941.37% in 2021 and then crashed by 7137.45% in 2022.
- Avricore Health's Cash & Equivalents (Quarter) stood at $1.6 million in 2021, then plummeted by 71.37% to $457144.1 in 2022, then tumbled by 55.56% to $203151.2 in 2023, then surged by 299.02% to $810621.9 in 2024, then grew by 1.48% to $822631.8 in 2025.
- Its Cash & Equivalents was $822631.8 in Q3 2025, compared to $817261.5 in Q2 2025 and $789182.6 in Q1 2025.